Newsbenzinga
iRadimed Sees Q4 Adj EPS $0.57-$0.61 vs $0.63 Est; Sees Sales $25.000M-$26.500M vs $26.233M Est
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…